` NMRD (Nemaura Medical Inc) vs S&P 500 Comparison - Alpha Spread

NMRD
vs
S&P 500

Over the past 12 months, NMRD has underperformed S&P 500, delivering a return of -100% compared to the S&P 500's +16% growth.

Stocks Performance
NMRD vs S&P 500

Loading
NMRD
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
NMRD vs S&P 500

Loading
NMRD
S&P 500
Difference
www.alphaspread.com

Performance By Year
NMRD vs S&P 500

Loading
NMRD
S&P 500
Add Stock

Competitors Performance
Nemaura Medical Inc vs Peers

Nemaura Medical Inc
Glance View

Market Cap
4k USD
Industry
Health Care

Nemaura Medical, Inc. operates as a holding company. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-11-04. The firm is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The firm's subsidiaries include Region Green Limited.

NMRD Intrinsic Value
Not Available
Back to Top